Literature DB >> 19322475

Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide.

Peter Faller1, Christelle Hureau.   

Abstract

In the present perspective, we give a critical review on the coordination chemistry of the metal ions copper and zinc to the amyloid-beta (Abeta) peptide; such complexes have been linked to Alzheimer's disease. We focus on two main issues: the identification of the coordination sphere of the Cu(ii) and Zn(ii) ions and the affinity of these metal ions towards the peptide. With the aim to come up with as few as possible valuable structural models and binding affinity values, we critically review the divergent propositions reported in the literature and take into account the experimental differences and the limits of the methods used in the published studies. We propose that: (i) the conditional dissociation constant of the Cu(Abeta) complexes lies in the range of 10 pM to 100 nM, with a preference for the region between 100 pM to 1 nM. (ii) Two most likely coordination modes for the predominant form of the Cu(Abeta) complexes at physiological pH can be retained, both being 3N1O distorted square planar. In the first model, the Cu(ii) ion is coordinated by the Ntau atoms of the three His residues and the carboxylate of the Asp1. In the second model, both the N-terminus and the carboxylate functions of Asp1 are ligated together with the Ntau of His6 and of His13 (or His14). An equilibrium between these two forms at room temperature, and a preferentially freezing out of the second one would explain most of the divergences in the published results (in particular, between those obtained by EPR and NMR). (iii) The apparent dissociation constants of Zn(Abeta) in various buffers are in the range of 1 to 20 muM (a 10 times lower conditional dissociation constant can be estimated. (iv) For the Zn(ii) coordination, the implication of the three His and the Asp1 residues is consensual. The Asp1 can be coordinated by the carboxylate and/or the N-terminus functions. Additional ligands are possible, such as Glu11 or H(2)O.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19322475     DOI: 10.1039/b813398k

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  97 in total

1.  Zinc ions promote Alzheimer Abeta aggregation via population shift of polymorphic states.

Authors:  Yifat Miller; Buyong Ma; Ruth Nussinov
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-06       Impact factor: 11.205

2.  In silico strategies for the selection of chelating compounds with potential application in metal-promoted neurodegenerative diseases.

Authors:  Cristina Rodríguez-Rodríguez; Albert Rimola; Jorge Alí-Torres; Mariona Sodupe; Pilar González-Duarte
Journal:  J Comput Aided Mol Des       Date:  2011-01       Impact factor: 3.686

3.  Development of bifunctional stilbene derivatives for targeting and modulating metal-amyloid-β species.

Authors:  Joseph J Braymer; Jung-Suk Choi; Alaina S DeToma; Chen Wang; Kisoo Nam; Jeffrey W Kampf; Ayyalusamy Ramamoorthy; Mi Hee Lim
Journal:  Inorg Chem       Date:  2011-09-28       Impact factor: 5.165

4.  Calorimetric investigation of copper(II) binding to Aβ peptides: thermodynamics of coordination plasticity.

Authors:  Cristina Sacco; Rachel A Skowronsky; Sunitha Gade; John M Kenney; Anne M Spuches
Journal:  J Biol Inorg Chem       Date:  2012-01-22       Impact factor: 3.358

5.  The effect of Cu(2+) and Zn(2+) on the Aβ42 peptide aggregation and cellular toxicity.

Authors:  Anuj K Sharma; Stephanie T Pavlova; Jaekwang Kim; Jungsu Kim; Liviu M Mirica
Journal:  Metallomics       Date:  2013-11       Impact factor: 4.526

6.  Interaction of apoNeuroglobin with heme-Aβ complexes relevant to Alzheimer's disease.

Authors:  Manas Seal; Sheetal Uppal; Suman Kundu; Somdatta Ghosh Dey
Journal:  J Biol Inorg Chem       Date:  2015-02-08       Impact factor: 3.358

7.  Substantial contribution of the two imidazole rings of the His13-His14 dyad to Cu(II) binding in amyloid-β(1-16) at physiological pH and its significance.

Authors:  Byong-kyu Shin; Sunil Saxena
Journal:  J Phys Chem A       Date:  2011-04-14       Impact factor: 2.781

8.  Rational design of a structural framework with potential use to develop chemical reagents that target and modulate multiple facets of Alzheimer's disease.

Authors:  Sanghyun Lee; Xueyun Zheng; Janarthanan Krishnamoorthy; Masha G Savelieff; Hyun Min Park; Jeffrey R Brender; Jin Hoon Kim; Jeffrey S Derrick; Akiko Kochi; Hyuck Jin Lee; Cheal Kim; Ayyalusamy Ramamoorthy; Michael T Bowers; Mi Hee Lim
Journal:  J Am Chem Soc       Date:  2013-12-27       Impact factor: 15.419

9.  Aroylhydrazones constitute a promising class of 'metal-protein attenuating compounds' for the treatment of Alzheimer's disease: a proof-of-concept based on the study of the interactions between zinc(II) and pyridine-2-carboxaldehyde isonicotinoyl hydrazone.

Authors:  Daphne S Cukierman; Elio Accardo; Rosana Garrido Gomes; Anna De Falco; Marco C Miotto; Maria Clara Ramalho Freitas; Mauricio Lanznaster; Claudio O Fernández; Nicolás A Rey
Journal:  J Biol Inorg Chem       Date:  2018-08-25       Impact factor: 3.358

10.  Ternary complexes of iron, amyloid-beta, and nitrilotriacetic acid: binding affinities, redox properties, and relevance to iron-induced oxidative stress in Alzheimer's disease.

Authors:  Dianlu Jiang; Xiangjun Li; Renee Williams; Sveti Patel; Lijie Men; Yinsheng Wang; Feimeng Zhou
Journal:  Biochemistry       Date:  2009-08-25       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.